MAPT and Alzheimer disease: Considering the significant association of plasma p-tau 181 and 217 with cognitive decline in cognitively unimpaired individuals and the conversion to pre-symptomatic Alzheimer’s disease,3,6–8 p-tau species may be considered good predictors of memory loss at Alzheimer’s disease preclinical stages.